Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024.
January 13, 2024
Share
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024. These A Shares will be under lockup for 1102 days starting from 7-JAN-2021 to 14-JAN-2024.
Details:
The company's controlling shareholder Hob Biotech Group Limited and actual controller WEIJUN LI, JOHN LI, Chen Tao committed within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. Shareholders Fuzhou Taihong Jinghui Equity Investment Partnership (Limited Partnership), Zhuhai Taihong Jinghui Equity Investment Partnership (Limited Partnership), Pingtan Jianfa Shihao Equity Investment Partnership (Limited Partnership); Directors and managing personnel in the Company; Supervisors in the Company and core technical personnel in the Company promised within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company.
Shareholders Guangzhou Jinhu Equity Investment Management Partnership (Limited Partnership), Guangzhou Xinmanli Investment Consulting Co., Lt promised within 12 months since the date of listing of the present shares, there will be no transfers nor entrustment of shares to any third party nor repurchase by the Company.
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.